Sharpe ratio
0.71Return earned for the risk taken.
Moderate
Moderate risk-adjusted returns. The reward for risk has been average.
+5.74%1Y Absolute Return
-0.28%1D
Loading NAV history…
Past performance is not an indicator of future returns.
Returns calculator comparison
Compare an illustrative investment outcome across return assumptions.
| Asset | Projected corpus | Total invested | Gain | Annual return |
|---|---|---|---|---|
| Mirae Asset Balanced Advantage Fund Direct Plan- GrowthFund 3Y annualised return · 5Y history unavailable | ₹9,72,002 | ₹7,32,612 | ₹2,39,390 | +11.50% |
| EPFIllustrative annual assumption | ₹8,95,132 | ₹7,32,612 | ₹1,62,520 | +8.25% |
| Residential propertyIllustrative annual assumption | ₹8,67,662 | ₹7,32,612 | ₹1,35,050 | +7.00% |
| PPFIllustrative annual assumption | ₹8,69,819 | ₹7,32,612 | ₹1,37,207 | +7.10% |
| Bank fixed depositIllustrative annual assumption | ₹8,56,981 | ₹7,32,612 | ₹1,24,369 | +6.50% |
| GoldIllustrative annual assumption | ₹8,67,662 | ₹7,32,612 | ₹1,35,050 | +7.00% |
| Savings accountIllustrative annual assumption | ₹7,86,827 | ₹7,32,612 | ₹54,215 | +3.00% |
Illustration only. Fund results use the available NAV-derived annualised return and can be negative. Reference rows are assumptions, not current quoted rates or guaranteed returns; property excludes transaction costs, taxes, and liquidity constraints. Mutual fund investments are subject to market risk.
Wealth multiple
₹1 became₹1.12
₹1 Lakh since launch₹1.12 Lakh
Fund age4.3 yrs
Fund information
Scheme code150470
ISININF769K01IN6
BenchmarkNIFTY 50 Hybrid Composite Debt 50:50 Index
CategoryHybrid Scheme - Dynamic Asset Allocation or Balanced Advantage
Expense ratio0.94%
Exit loadExit Load for units in excess of 15% of the investment,1% will be charged for redemption within 180 Days.
Minimum SIP₹99 SIP
Return comparison
11th / 145 in category| Period | Fund | Benchmark | Category avg |
|---|---|---|---|
| 1M | +89.85% | — | — |
| 3M | +9.48% | — | — |
| 6M | +13.05% | — | — |
| 1Y | +5.74% | — | +0.31% |
| 3Y | +11.50% | — | +7.18% |
| Since Launch | +11.64% | — | — |
Risk-adjusted performance
Every measure is expanded with a plain-language reading of the latest calculated value.
Sortino ratio
1.03Return earned while limiting downside risk.
Good
Good downside protection with strong returns.
Standard deviation
8.27%How much the fund’s returns fluctuate over time.
Low volatility
Returns have been relatively stable.
Beta
—How closely the fund moves with the market.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Alpha
—Extra return generated above the benchmark.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Treynor ratio
—Return earned for each unit of market risk taken.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Calmar ratio
1.55How well the fund rewarded investors relative to its biggest decline.
Excellent
Excellent balance between returns and drawdowns.
Information ratio
—How consistently the fund outperformed its benchmark.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Portfolio allocation
Latest disclosed portfolio mix
Asset allocation
Portfolio100%
Equity56.51%
Debt27.72%
Hedged Equity12.07%
Cash3.70%
Market cap allocation
Sector allocation
Equity exposure by sector
Top holdings
10 of 185 disclosed positions
| Holding | Sector | Instrument type | Weight |
|---|---|---|---|
| Cash Margin | Unspecified | Cash Margin | 12.0668% |
| HDFC Bank Ltd | Financial | Equity | 5.2391% |
| ICICI Bank Ltd | Financial | Equity | 3.6315% |
| GOI Sec 7.18 14/08/2033 | Entities | GOI Securities | 3.3988% |
| Bharti Airtel Ltd | Technology | Equity | 2.9481% |
| Reliance Industries Ltd | Energy & Utilities | Equity | 2.8389% |
| State Bank of India | Financial | Equity | 2.7988% |
| TORRENT PHARMACEUTICALS LTD SR 2 7.60 NCD 19JN29 FVRS1LAC | Healthcare | Non Convertible Debenture | 2.3439% |
| CHOLAMANDALAM INVESTMENT AND FINANCE COMPANY LIMITED SR 662 7.94 NCD 20MR29 FVRS1LAC | Financial | Bonds | 2.2943% |
| Net Receivables | Unspecified | Net Receivables | 2.0005% |
Fund management
HA
Harshad Borawake
Since 2022 · Prior to joining Mirae Asset Mutual Fund, he has worked with Motilal Oswal Securities Ltd. as Vice President and Capmetrics & Risk Solutions Private Ltd. as Research Analyst - Equity.
Mr. Borawake is MBA(Finance) & B.E.(Polymers)
BA
Basant Bafna
Since 2025 · Prior to joining Mirae Asset Mutual Fund, he has worked with India Exim Bank and Union Bank of India
Mr. Bafna has done B.Com, MBA, CS, CA, FRM and CFA
Compare similar funds
No comparable category funds are available yet.
Summary
A very high-risk hybrid scheme - dynamic asset allocation or balanced advantage fund. Ahead of its category average over 3Y by 4.3 points.
Strengths
- Ahead of its category average over 3Y by 4.3 points.
- Losses and swings stayed contained — worst fall -7.5%, volatility 8.3%.
- Recovered from its worst fall in 2 months.
- Well spread out — top 10 holdings are only 25% of the portfolio.
- Ranks 11 of 145 in its category over 1 year.
Weaknesses
- None
Ideal investor
- Needs a 4–5+ years horizon to ride out its very high risk level.
- Good fit for SIPs — spreading purchases smooths out 8.3% volatility.
Risk drivers
- None